Literature DB >> 20516219

p38 mitogen-activated protein kinase promotes cell survival in response to DNA damage but is not required for the G(2) DNA damage checkpoint in human cancer cells.

Mark S Phong1, Robert D Van Horn, Shuyu Li, Gregory Tucker-Kellogg, Uttam Surana, Xiang S Ye.   

Abstract

p38 mitogen-activated protein kinase (MAPK) is rapidly activated by stresses and is believed to play an important role in the stress response. While Chk1 is known to mediate G(2) DNA damage checkpoint control, p38 was also reported to have an essential function in this checkpoint control. Here, we have investigated further the roles of p38 and Chk1 in the G(2) DNA damage checkpoint in cancer cells. We find that although p38 activation is strongly induced by DNA damage, its activity is not required for the G(2) DNA damage checkpoint. In contrast, Chk1 kinase is responsible for the execution of G(2) DNA damage checkpoint control in p53-deficient cells. The inhibition of p38 activity has no effect on Chk1 activation and gamma-H2AX expression. Global gene expression profiling of cancer cells in response to tumor necrosis factor alpha (TNF-alpha) revealed that p38 plays a strong prosurvival role through the coordinated downregulation of proapoptotic genes and upregulation of prosurvival genes. We show that the inhibition of p38 activity during G(2) DNA damage checkpoint arrest triggers apoptosis in a p53-independent manner with a concurrent decrease in the level of Bcl2 family proteins. Our results suggest that although p38 MAPK is not required for the G(2) DNA damage checkpoint function, it plays an important prosurvival role during the G(2) DNA damage checkpoint response through the upregulation of the Bcl2 family proteins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20516219      PMCID: PMC2916406          DOI: 10.1128/MCB.00949-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

Review 1.  The p38 signal transduction pathway: activation and function.

Authors:  K Ono; J Han
Journal:  Cell Signal       Date:  2000-01       Impact factor: 4.315

2.  Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase.

Authors:  Alwin Krämer; Niels Mailand; Claudia Lukas; Randi G Syljuåsen; Christopher J Wilkinson; Erich A Nigg; Jiri Bartek; Jiri Lukas
Journal:  Nat Cell Biol       Date:  2004-08-15       Impact factor: 28.824

3.  Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.

Authors:  Zhan Xiao; Zehan Chen; Angelo H Gunasekera; Thomas J Sowin; Saul H Rosenberg; Steve Fesik; Haiying Zhang
Journal:  J Biol Chem       Date:  2003-04-03       Impact factor: 5.157

4.  Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation.

Authors:  D V Bulavin; S Saito; M C Hollander; K Sakaguchi; C W Anderson; E Appella; A J Fornace
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

5.  An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage.

Authors:  J R Jackson; A Gilmartin; C Imburgia; J D Winkler; L A Marshall; A Roshak
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

6.  Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase.

Authors:  D V Bulavin; Y Higashimoto; I J Popoff; W A Gaarde; V Basrur; O Potapova; E Appella; A J Fornace
Journal:  Nature       Date:  2001-05-03       Impact factor: 49.962

7.  Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells.

Authors:  K Koniaras; A R Cuddihy; H Christopoulos; A Hogg; M J O'Connell
Journal:  Oncogene       Date:  2001-11-08       Impact factor: 9.867

8.  p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L).

Authors:  Simone Grethe; Mikko P S Ares; Tommy Andersson; M Isabella Pörn-Ares
Journal:  Exp Cell Res       Date:  2004-08-15       Impact factor: 3.905

9.  Cooperative function of Chk1 and p38 pathways in activating G2 arrest following exposure to temozolomide.

Authors:  Yuichi Hirose; Makoto Katayama; Mitchel S Berger; Russell O Pieper
Journal:  J Neurosurg       Date:  2004-06       Impact factor: 5.115

10.  Opposing roles of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in the cellular response to ionizing radiation in human cervical cancer cells.

Authors:  Min-Jung Kim; Soon-Young Choi; In-Chul Park; Sang-Gu Hwang; Changil Kim; Young-Hyun Choi; Haekwon Kim; Kee-Ho Lee; Su-Jae Lee
Journal:  Mol Cancer Res       Date:  2008-11       Impact factor: 5.852

View more
  25 in total

1.  Control of Trx1 redox state modulates protection against methyl methanesulfonate-induced DNA damage via stabilization of p21.

Authors:  Li Gu; Wei Gao; Hui Min Yang; Bei Bei Wang; Xiao Na Wang; Jianguo Xu; Hong Zhang
Journal:  J Biochem       Date:  2015-08-13       Impact factor: 3.387

2.  TLR signaling modulates side effects of anticancer therapy in the small intestine.

Authors:  Magdalena Frank; Eva Maria Hennenberg; Annette Eyking; Michael Rünzi; Guido Gerken; Paul Scott; Julian Parkhill; Alan W Walker; Elke Cario
Journal:  J Immunol       Date:  2015-01-14       Impact factor: 5.422

3.  Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease.

Authors:  Juliane Totzke; Deepak Gurbani; Rene Raphemot; Philip F Hughes; Khaldon Bodoor; David A Carlson; David R Loiselle; Asim K Bera; Liesl S Eibschutz; Marisha M Perkins; Amber L Eubanks; Phillip L Campbell; David A Fox; Kenneth D Westover; Timothy A J Haystead; Emily R Derbyshire
Journal:  Cell Chem Biol       Date:  2017-08-17       Impact factor: 8.116

Review 4.  The Bidirectional Link Between RNA Cleavage and Polyadenylation and Genome Stability: Recent Insights From a Systematic Screen.

Authors:  Stefano Spada; Brian Luke; Sven Danckwardt
Journal:  Front Genet       Date:  2022-04-28       Impact factor: 4.772

5.  Small molecules capable of activating DNA methylation-repressed genes targeted by the p38 mitogen-activated protein kinase pathway.

Authors:  Xiang Li; Erchang Shang; Qiang Dong; Yingfeng Li; Jing Zhang; Shaohua Xu; Zuodong Zhao; Wei Shao; Cong Lv; Yong Zheng; Hailin Wang; Xiaoguang Lei; Bing Zhu; Zhuqiang Zhang
Journal:  J Biol Chem       Date:  2018-03-20       Impact factor: 5.157

6.  Nodal expression in triple-negative breast cancer: Cellular effects of its inhibition following doxorubicin treatment.

Authors:  Thomas M Bodenstine; Grace S Chandler; David W Reed; Naira V Margaryan; Alina Gilgur; Janis Atkinson; Nida Ahmed; Matthew Hyser; Elisabeth A Seftor; Luigi Strizzi; Mary J C Hendrix
Journal:  Cell Cycle       Date:  2016-05-02       Impact factor: 4.534

7.  ERK/MAPK is essential for endogenous neuroprotection in SCN2.2 cells.

Authors:  Sumedha W Karmarkar; Kathleen M Bottum; Stacey L Krager; Shelley A Tischkau
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

8.  PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.

Authors:  Sun Hee Park; Koichi Ito; William Olcott; Igor Katsyv; Gwyneth Halstead-Nussloch; Hanna Y Irie
Journal:  Breast Cancer Res       Date:  2015-06-19       Impact factor: 6.466

9.  Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells.

Authors:  M R Milone; B Pucci; F Bruzzese; C Carbone; G Piro; S Costantini; F Capone; A Leone; E Di Gennaro; M Caraglia; A Budillon
Journal:  Cell Death Dis       Date:  2013-05-23       Impact factor: 8.469

10.  Hydrogen peroxide (H2O2) induces leukemic but not normal hematopoietic cell death in a dose-dependent manner.

Authors:  Amanda Nogueira-Pedro; Thalyta Aparecida Munhoz Cesário; Carolina Carvalho Dias; Clarice Silvia Taemi Origassa; Lilian Piñero Marcolin Eça; Edgar Julian Paredes-Gamero; Alice Teixeira Ferreira
Journal:  Cancer Cell Int       Date:  2013-12-23       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.